AUTO-T 

Cell Therapy Manufacturing Platform

RESI-23-034 Design Comps_Website Header SnapLVV v1-1

ACCELERATE SPEED TO CLINIC, REDUCE PATIENT WAIT TIMES

Immunotherapies offer hope to cure patients in need, and it’s time to deliver a better manufacturing outcome for these life-saving therapies. As you navigate the journey to get to clinical trials for your cell therapy, you need a partner you can trust to guide you through the complex regulatory landscape, to increase the manufacturability of your therapy, and ultimately, to secure your path to commercialization and get it in the hands of those in need.

FROM PROJECT INITIATION TO CLINICAL READINESS IN UNDER 12 MONTHS

The Auto-T cell therapy manufacturing platform from Resilience offers therapeutic innovators a vetted and accelerated pathway to clinical trials. Auto-T is an end-to-end manufacturing and assay platform for LVV-based autologous CAR-T and TCR-T cell therapies containing all required regulatory support to get your clinical trial started within one year of signing on. Gain access to a platform that is well characterized with all release testing performed in-house for maximum efficiency. Auto-T accelerates your time to clinical readiness and gets your cell therapy innovation to patients faster.  

All development, manufacturing and testing/quality operations take place inside our 85,000 sq. ft. Center of Excellence for Cellular Immunotherapy located outside of Philadelphia, PA. As your trusted cell therapy CDMO partner, Resilience is giving you access to the most advanced technologies to build a resilient tomorrow, today. 

Resilience-Cell-Therapy-Labs

AUTO-T PLATFORM HIGHLIGHTS

Resilience_Iconography_Other_WHITE_Resilience_Icon_ArrowBottom
Speed to Clinical Trial
 Auto-T can get you from project initiation to clinical readiness in under one year 
Resilience_Iconography_Other_WHITE_Resilience_Icon_Industry
Consistent Performance Profile
Performs consistently with various vectors, constructs, and payload sizes to meet your needs 
Resilience_Iconography_Other_WHITE_Resilience_Icon_Path
Regulatory Expertise
Processes and analytics are fully developed and vetted. Featured in multiple Investigational New Drug (IND) applications 
Resilience_Icon_Collaborate - KO White
Digitally Enabled
De-risk manufacturing and accelerate release timelines with paperless manufacturing
Resilience_Iconography_Other_WHITE_Resilience_Icon_Platform
Modular and Flexible
Modifiable unit operations to adapt to your product specific needs, including different vectors and gene editing technologies  
Resilience_Iconography_Other_WHITE_Resilience_Icon_MeetingRoom
Transparent Terms
Terms are discussed up-front with no hidden catches while providing you full process portability. 
Cell therapies are unique. Connect with us to discuss your innovation and we can provide a timeline to get to the clinic.
LET'S TALK CELL THERAPY. AND YOUR SUCCESS

Is your current program a good fit for Auto-T?  Let’s connect and talk more about what’s driving your needs, objectives, and project dynamics.

NATIONAL RESILIENCE